Aran Biomedical Teoranta Announces the Appointment of Todd Blair to the Newly Created Role of VP US Sales & Business Development

HRS Scientific Sessions: Boston Scientific LBCT

During the Heart Rhythm Scientific Sessions this week, Boston Scientific announced positive LBCT data underscoring the safety and efficacy of multi-site pacing (MSP) over conventional cardiac resynchronization therapy (CRT), as well as poster presentations on real-world use of the WATCHMAN Left Atrial Appendage Closure (LAAC) device and next-generation WATCHMAN FLX LAAC device as alternatives to oral anticoagulation therapy for stroke risk reduction in patients with non-valvular atrial fibrillation.

What are the Most Commonly Performed Surgeries?

Whether you are trying to learn more about a surgery you are planning to have or find out what the most common procedures are, this list is here for you. Read more.

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

June 29, 2020

Aran Biomedical announced the appointment of Mr. Todd Blair as Vice President of Sales and Business Development (US), with effect 1st July 2020.

Aran Biomedical notes this role has been created to meet and manage the growing demand for the companies implantable biomaterial product solutions. Todd will be responsible for leading the Company’s sales and business development activities in the US marketplace with a primary focus on the Orthopaedic, General Surgery and Vascular fields.

Todd Blair joins the company from Heraeus Medical Components where he held the role of Vice President of Corporate Strategy. Todd brings more than 20 years of experience in sales and business development within the life sciences contract manufacturing industry, with a focus on implantable materials and technologies; including Bio-Textiles, Nitinol devices and polymeric components. Todd will support the companies growth plans by identifying new business opportunities and developing and growing those relationships into sustainable and long-term partnerships. In addition, Todd will support internal teams on proposal and product solution development.

“We welcome Todd to Aran Biomedical and are delighted to appoint a candidate of his calibre as Vice President of Sales and Business Development (US),” said Peter Mulrooney CEO, of the company. “The creation of this new position highlights the increasing level of interest Aran Biomedical is seeing in our implantable biomaterial products and services. It also demonstrates the importance of the US market to Aran Biomedical’s growth and expansion plans. We look forward to benefiting from Todd’s vast biomedical textile experience and contact network, to further expand our market presence, particularly for the Orthopaedics, Vascular and General Surgery fields, which are our key growth drivers.”

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.